ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Recombinant III Humanized Collagen Patch Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-39D16383
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Medical Recombinant III Humanized Collagen Patch Market Research Report 2024
BUY CHAPTERS

Global Medical Recombinant III Humanized Collagen Patch Market Research Report 2025

Code: QYRE-Auto-39D16383
Report
September 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Huanji

Medical Recombinant III Humanized Collagen Patch Market Size

The global market for Medical Recombinant III Humanized Collagen Patch was valued at US$ 96 million in the year 2024 and is projected to reach a revised size of US$ 189 million by 2031, growing at a CAGR of 10.3% during the forecast period.

Medical Recombinant III Humanized Collagen Patch Market

Medical Recombinant III Humanized Collagen Patch Market

North American market for Medical Recombinant III Humanized Collagen Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Medical Recombinant III Humanized Collagen Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Medical Recombinant III Humanized Collagen Patch include Harbin Fuerjia Technology Co., Ltd., Guangdong Andao Medical Apparatus And Instruments Co., Ltd., Hunan Bade Medical Technology Co., Ltd., Huanji, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medical Recombinant III Humanized Collagen Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Recombinant III Humanized Collagen Patch.
The Medical Recombinant III Humanized Collagen Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical Recombinant III Humanized Collagen Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Recombinant III Humanized Collagen Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Medical Recombinant III Humanized Collagen Patch Market Report

Report Metric Details
Report Name Medical Recombinant III Humanized Collagen Patch Market
Accounted market size in year US$ 96 million
Forecasted market size in 2031 US$ 189 million
CAGR 10.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Collagen Content ≥ 0.2 mg/g
  • Collagen Content ≥ 0.3 mg/g
  • Collagen Content ≥ 0.5 mg/g
  • Others
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Harbin Fuerjia Technology Co., Ltd., Guangdong Andao Medical Apparatus And Instruments Co., Ltd., Hunan Bade Medical Technology Co., Ltd., Huanji
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Medical Recombinant III Humanized Collagen Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Medical Recombinant III Humanized Collagen Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Medical Recombinant III Humanized Collagen Patch Market growing?

Ans: The Medical Recombinant III Humanized Collagen Patch Market witnessing a CAGR of 10.3% during the forecast period 2025-2031.

What is the Medical Recombinant III Humanized Collagen Patch Market size in 2031?

Ans: The Medical Recombinant III Humanized Collagen Patch Market size in 2031 will be US$ 189 million.

Who are the main players in the Medical Recombinant III Humanized Collagen Patch Market report?

Ans: The main players in the Medical Recombinant III Humanized Collagen Patch Market are Harbin Fuerjia Technology Co., Ltd., Guangdong Andao Medical Apparatus And Instruments Co., Ltd., Hunan Bade Medical Technology Co., Ltd., Huanji

What are the Application segmentation covered in the Medical Recombinant III Humanized Collagen Patch Market report?

Ans: The Applications covered in the Medical Recombinant III Humanized Collagen Patch Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Medical Recombinant III Humanized Collagen Patch Market report?

Ans: The Types covered in the Medical Recombinant III Humanized Collagen Patch Market report are Collagen Content ≥ 0.2 mg/g, Collagen Content ≥ 0.3 mg/g, Collagen Content ≥ 0.5 mg/g, Others

1 Medical Recombinant III Humanized Collagen Patch Market Overview
1.1 Product Definition
1.2 Medical Recombinant III Humanized Collagen Patch by Type
1.2.1 Global Medical Recombinant III Humanized Collagen Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 Collagen Content ≥ 0.2 mg/g
1.2.3 Collagen Content ≥ 0.3 mg/g
1.2.4 Collagen Content ≥ 0.5 mg/g
1.2.5 Others
1.3 Medical Recombinant III Humanized Collagen Patch by Application
1.3.1 Global Medical Recombinant III Humanized Collagen Patch Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Medical Recombinant III Humanized Collagen Patch Market Size Estimates and Forecasts
1.4.1 Global Medical Recombinant III Humanized Collagen Patch Revenue 2020-2031
1.4.2 Global Medical Recombinant III Humanized Collagen Patch Sales 2020-2031
1.4.3 Global Medical Recombinant III Humanized Collagen Patch Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Medical Recombinant III Humanized Collagen Patch Market Competition by Manufacturers
2.1 Global Medical Recombinant III Humanized Collagen Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Medical Recombinant III Humanized Collagen Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Medical Recombinant III Humanized Collagen Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Recombinant III Humanized Collagen Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Recombinant III Humanized Collagen Patch, Product Type & Application
2.7 Global Key Manufacturers of Medical Recombinant III Humanized Collagen Patch, Date of Enter into This Industry
2.8 Global Medical Recombinant III Humanized Collagen Patch Market Competitive Situation and Trends
2.8.1 Global Medical Recombinant III Humanized Collagen Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Medical Recombinant III Humanized Collagen Patch Players Market Share by Revenue
2.8.3 Global Medical Recombinant III Humanized Collagen Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Recombinant III Humanized Collagen Patch Market Scenario by Region
3.1 Global Medical Recombinant III Humanized Collagen Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Medical Recombinant III Humanized Collagen Patch Sales by Region: 2020-2031
3.2.1 Global Medical Recombinant III Humanized Collagen Patch Sales by Region: 2020-2025
3.2.2 Global Medical Recombinant III Humanized Collagen Patch Sales by Region: 2026-2031
3.3 Global Medical Recombinant III Humanized Collagen Patch Revenue by Region: 2020-2031
3.3.1 Global Medical Recombinant III Humanized Collagen Patch Revenue by Region: 2020-2025
3.3.2 Global Medical Recombinant III Humanized Collagen Patch Revenue by Region: 2026-2031
3.4 North America Medical Recombinant III Humanized Collagen Patch Market Facts & Figures by Country
3.4.1 North America Medical Recombinant III Humanized Collagen Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Medical Recombinant III Humanized Collagen Patch Sales by Country (2020-2031)
3.4.3 North America Medical Recombinant III Humanized Collagen Patch Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Recombinant III Humanized Collagen Patch Market Facts & Figures by Country
3.5.1 Europe Medical Recombinant III Humanized Collagen Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Medical Recombinant III Humanized Collagen Patch Sales by Country (2020-2031)
3.5.3 Europe Medical Recombinant III Humanized Collagen Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Recombinant III Humanized Collagen Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Recombinant III Humanized Collagen Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Medical Recombinant III Humanized Collagen Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Medical Recombinant III Humanized Collagen Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical Recombinant III Humanized Collagen Patch Market Facts & Figures by Country
3.7.1 Latin America Medical Recombinant III Humanized Collagen Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Medical Recombinant III Humanized Collagen Patch Sales by Country (2020-2031)
3.7.3 Latin America Medical Recombinant III Humanized Collagen Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical Recombinant III Humanized Collagen Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Recombinant III Humanized Collagen Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Medical Recombinant III Humanized Collagen Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Medical Recombinant III Humanized Collagen Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Recombinant III Humanized Collagen Patch Sales by Type (2020-2031)
4.1.1 Global Medical Recombinant III Humanized Collagen Patch Sales by Type (2020-2025)
4.1.2 Global Medical Recombinant III Humanized Collagen Patch Sales by Type (2026-2031)
4.1.3 Global Medical Recombinant III Humanized Collagen Patch Sales Market Share by Type (2020-2031)
4.2 Global Medical Recombinant III Humanized Collagen Patch Revenue by Type (2020-2031)
4.2.1 Global Medical Recombinant III Humanized Collagen Patch Revenue by Type (2020-2025)
4.2.2 Global Medical Recombinant III Humanized Collagen Patch Revenue by Type (2026-2031)
4.2.3 Global Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Type (2020-2031)
4.3 Global Medical Recombinant III Humanized Collagen Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Medical Recombinant III Humanized Collagen Patch Sales by Application (2020-2031)
5.1.1 Global Medical Recombinant III Humanized Collagen Patch Sales by Application (2020-2025)
5.1.2 Global Medical Recombinant III Humanized Collagen Patch Sales by Application (2026-2031)
5.1.3 Global Medical Recombinant III Humanized Collagen Patch Sales Market Share by Application (2020-2031)
5.2 Global Medical Recombinant III Humanized Collagen Patch Revenue by Application (2020-2031)
5.2.1 Global Medical Recombinant III Humanized Collagen Patch Revenue by Application (2020-2025)
5.2.2 Global Medical Recombinant III Humanized Collagen Patch Revenue by Application (2026-2031)
5.2.3 Global Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Application (2020-2031)
5.3 Global Medical Recombinant III Humanized Collagen Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Harbin Fuerjia Technology Co., Ltd.
6.1.1 Harbin Fuerjia Technology Co., Ltd. Company Information
6.1.2 Harbin Fuerjia Technology Co., Ltd. Description and Business Overview
6.1.3 Harbin Fuerjia Technology Co., Ltd. Medical Recombinant III Humanized Collagen Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Harbin Fuerjia Technology Co., Ltd. Medical Recombinant III Humanized Collagen Patch Product Portfolio
6.1.5 Harbin Fuerjia Technology Co., Ltd. Recent Developments/Updates
6.2 Guangdong Andao Medical Apparatus And Instruments Co., Ltd.
6.2.1 Guangdong Andao Medical Apparatus And Instruments Co., Ltd. Company Information
6.2.2 Guangdong Andao Medical Apparatus And Instruments Co., Ltd. Description and Business Overview
6.2.3 Guangdong Andao Medical Apparatus And Instruments Co., Ltd. Medical Recombinant III Humanized Collagen Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Guangdong Andao Medical Apparatus And Instruments Co., Ltd. Medical Recombinant III Humanized Collagen Patch Product Portfolio
6.2.5 Guangdong Andao Medical Apparatus And Instruments Co., Ltd. Recent Developments/Updates
6.3 Hunan Bade Medical Technology Co., Ltd.
6.3.1 Hunan Bade Medical Technology Co., Ltd. Company Information
6.3.2 Hunan Bade Medical Technology Co., Ltd. Description and Business Overview
6.3.3 Hunan Bade Medical Technology Co., Ltd. Medical Recombinant III Humanized Collagen Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hunan Bade Medical Technology Co., Ltd. Medical Recombinant III Humanized Collagen Patch Product Portfolio
6.3.5 Hunan Bade Medical Technology Co., Ltd. Recent Developments/Updates
6.4 Huanji
6.4.1 Huanji Company Information
6.4.2 Huanji Description and Business Overview
6.4.3 Huanji Medical Recombinant III Humanized Collagen Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Huanji Medical Recombinant III Humanized Collagen Patch Product Portfolio
6.4.5 Huanji Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Recombinant III Humanized Collagen Patch Industry Chain Analysis
7.2 Medical Recombinant III Humanized Collagen Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Recombinant III Humanized Collagen Patch Production Mode & Process Analysis
7.4 Medical Recombinant III Humanized Collagen Patch Sales and Marketing
7.4.1 Medical Recombinant III Humanized Collagen Patch Sales Channels
7.4.2 Medical Recombinant III Humanized Collagen Patch Distributors
7.5 Medical Recombinant III Humanized Collagen Patch Customer Analysis
8 Medical Recombinant III Humanized Collagen Patch Market Dynamics
8.1 Medical Recombinant III Humanized Collagen Patch Industry Trends
8.2 Medical Recombinant III Humanized Collagen Patch Market Drivers
8.3 Medical Recombinant III Humanized Collagen Patch Market Challenges
8.4 Medical Recombinant III Humanized Collagen Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Huanji
List of Tables
 Table 1. Global Medical Recombinant III Humanized Collagen Patch Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Medical Recombinant III Humanized Collagen Patch Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Medical Recombinant III Humanized Collagen Patch Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Medical Recombinant III Humanized Collagen Patch Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Medical Recombinant III Humanized Collagen Patch Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Medical Recombinant III Humanized Collagen Patch Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Medical Recombinant III Humanized Collagen Patch Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Medical Recombinant III Humanized Collagen Patch Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Medical Recombinant III Humanized Collagen Patch, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Medical Recombinant III Humanized Collagen Patch, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Medical Recombinant III Humanized Collagen Patch, Product Type & Application
 Table 12. Global Key Manufacturers of Medical Recombinant III Humanized Collagen Patch, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Medical Recombinant III Humanized Collagen Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Recombinant III Humanized Collagen Patch as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Medical Recombinant III Humanized Collagen Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Medical Recombinant III Humanized Collagen Patch Sales by Region (2020-2025) & (K Units)
 Table 18. Global Medical Recombinant III Humanized Collagen Patch Sales Market Share by Region (2020-2025)
 Table 19. Global Medical Recombinant III Humanized Collagen Patch Sales by Region (2026-2031) & (K Units)
 Table 20. Global Medical Recombinant III Humanized Collagen Patch Sales Market Share by Region (2026-2031)
 Table 21. Global Medical Recombinant III Humanized Collagen Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Region (2020-2025)
 Table 23. Global Medical Recombinant III Humanized Collagen Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Region (2026-2031)
 Table 25. North America Medical Recombinant III Humanized Collagen Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Medical Recombinant III Humanized Collagen Patch Sales by Country (2020-2025) & (K Units)
 Table 27. North America Medical Recombinant III Humanized Collagen Patch Sales by Country (2026-2031) & (K Units)
 Table 28. North America Medical Recombinant III Humanized Collagen Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Medical Recombinant III Humanized Collagen Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Medical Recombinant III Humanized Collagen Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Medical Recombinant III Humanized Collagen Patch Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Medical Recombinant III Humanized Collagen Patch Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Medical Recombinant III Humanized Collagen Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Medical Recombinant III Humanized Collagen Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Medical Recombinant III Humanized Collagen Patch Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Medical Recombinant III Humanized Collagen Patch Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Medical Recombinant III Humanized Collagen Patch Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Medical Recombinant III Humanized Collagen Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Medical Recombinant III Humanized Collagen Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Medical Recombinant III Humanized Collagen Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Medical Recombinant III Humanized Collagen Patch Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Medical Recombinant III Humanized Collagen Patch Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Medical Recombinant III Humanized Collagen Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Medical Recombinant III Humanized Collagen Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Medical Recombinant III Humanized Collagen Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Medical Recombinant III Humanized Collagen Patch Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Medical Recombinant III Humanized Collagen Patch Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Medical Recombinant III Humanized Collagen Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Medical Recombinant III Humanized Collagen Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Medical Recombinant III Humanized Collagen Patch Sales (K Units) by Type (2020-2025)
 Table 51. Global Medical Recombinant III Humanized Collagen Patch Sales (K Units) by Type (2026-2031)
 Table 52. Global Medical Recombinant III Humanized Collagen Patch Sales Market Share by Type (2020-2025)
 Table 53. Global Medical Recombinant III Humanized Collagen Patch Sales Market Share by Type (2026-2031)
 Table 54. Global Medical Recombinant III Humanized Collagen Patch Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Medical Recombinant III Humanized Collagen Patch Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Type (2020-2025)
 Table 57. Global Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Type (2026-2031)
 Table 58. Global Medical Recombinant III Humanized Collagen Patch Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Medical Recombinant III Humanized Collagen Patch Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Medical Recombinant III Humanized Collagen Patch Sales (K Units) by Application (2020-2025)
 Table 61. Global Medical Recombinant III Humanized Collagen Patch Sales (K Units) by Application (2026-2031)
 Table 62. Global Medical Recombinant III Humanized Collagen Patch Sales Market Share by Application (2020-2025)
 Table 63. Global Medical Recombinant III Humanized Collagen Patch Sales Market Share by Application (2026-2031)
 Table 64. Global Medical Recombinant III Humanized Collagen Patch Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Medical Recombinant III Humanized Collagen Patch Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Application (2020-2025)
 Table 67. Global Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Application (2026-2031)
 Table 68. Global Medical Recombinant III Humanized Collagen Patch Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Medical Recombinant III Humanized Collagen Patch Price (US$/Unit) by Application (2026-2031)
 Table 70. Harbin Fuerjia Technology Co., Ltd. Company Information
 Table 71. Harbin Fuerjia Technology Co., Ltd. Description and Business Overview
 Table 72. Harbin Fuerjia Technology Co., Ltd. Medical Recombinant III Humanized Collagen Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Harbin Fuerjia Technology Co., Ltd. Medical Recombinant III Humanized Collagen Patch Product
 Table 74. Harbin Fuerjia Technology Co., Ltd. Recent Developments/Updates
 Table 75. Guangdong Andao Medical Apparatus And Instruments Co., Ltd. Company Information
 Table 76. Guangdong Andao Medical Apparatus And Instruments Co., Ltd. Description and Business Overview
 Table 77. Guangdong Andao Medical Apparatus And Instruments Co., Ltd. Medical Recombinant III Humanized Collagen Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Guangdong Andao Medical Apparatus And Instruments Co., Ltd. Medical Recombinant III Humanized Collagen Patch Product
 Table 79. Guangdong Andao Medical Apparatus And Instruments Co., Ltd. Recent Developments/Updates
 Table 80. Hunan Bade Medical Technology Co., Ltd. Company Information
 Table 81. Hunan Bade Medical Technology Co., Ltd. Description and Business Overview
 Table 82. Hunan Bade Medical Technology Co., Ltd. Medical Recombinant III Humanized Collagen Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hunan Bade Medical Technology Co., Ltd. Medical Recombinant III Humanized Collagen Patch Product
 Table 84. Hunan Bade Medical Technology Co., Ltd. Recent Developments/Updates
 Table 85. Huanji Company Information
 Table 86. Huanji Description and Business Overview
 Table 87. Huanji Medical Recombinant III Humanized Collagen Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Huanji Medical Recombinant III Humanized Collagen Patch Product
 Table 89. Huanji Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Medical Recombinant III Humanized Collagen Patch Distributors List
 Table 93. Medical Recombinant III Humanized Collagen Patch Customers List
 Table 94. Medical Recombinant III Humanized Collagen Patch Market Trends
 Table 95. Medical Recombinant III Humanized Collagen Patch Market Drivers
 Table 96. Medical Recombinant III Humanized Collagen Patch Market Challenges
 Table 97. Medical Recombinant III Humanized Collagen Patch Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medical Recombinant III Humanized Collagen Patch
 Figure 2. Global Medical Recombinant III Humanized Collagen Patch Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Medical Recombinant III Humanized Collagen Patch Market Share by Type: 2024 & 2031
 Figure 4. Collagen Content ≥ 0.2 mg/g Product Picture
 Figure 5. Collagen Content ≥ 0.3 mg/g Product Picture
 Figure 6. Collagen Content ≥ 0.5 mg/g Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Medical Recombinant III Humanized Collagen Patch Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Medical Recombinant III Humanized Collagen Patch Market Share by Application: 2024 & 2031
 Figure 10. Online Sales
 Figure 11. Offline Sales
 Figure 12. Global Medical Recombinant III Humanized Collagen Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Medical Recombinant III Humanized Collagen Patch Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Medical Recombinant III Humanized Collagen Patch Sales (2020-2031) & (K Units)
 Figure 15. Global Medical Recombinant III Humanized Collagen Patch Average Price (US$/Unit) & (2020-2031)
 Figure 16. Medical Recombinant III Humanized Collagen Patch Report Years Considered
 Figure 17. Medical Recombinant III Humanized Collagen Patch Sales Share by Manufacturers in 2024
 Figure 18. Global Medical Recombinant III Humanized Collagen Patch Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Medical Recombinant III Humanized Collagen Patch Players: Market Share by Revenue in Medical Recombinant III Humanized Collagen Patch in 2024
 Figure 20. Medical Recombinant III Humanized Collagen Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Medical Recombinant III Humanized Collagen Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Medical Recombinant III Humanized Collagen Patch Sales Market Share by Country (2020-2031)
 Figure 23. North America Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Country (2020-2031)
 Figure 24. United States Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Medical Recombinant III Humanized Collagen Patch Sales Market Share by Country (2020-2031)
 Figure 27. Europe Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Medical Recombinant III Humanized Collagen Patch Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Region (2020-2031)
 Figure 35. China Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Medical Recombinant III Humanized Collagen Patch Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Colombia Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Medical Recombinant III Humanized Collagen Patch Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Medical Recombinant III Humanized Collagen Patch Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Medical Recombinant III Humanized Collagen Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Medical Recombinant III Humanized Collagen Patch by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Medical Recombinant III Humanized Collagen Patch by Type (2020-2031)
 Figure 55. Global Medical Recombinant III Humanized Collagen Patch Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Medical Recombinant III Humanized Collagen Patch by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Medical Recombinant III Humanized Collagen Patch by Application (2020-2031)
 Figure 58. Global Medical Recombinant III Humanized Collagen Patch Price (US$/Unit) by Application (2020-2031)
 Figure 59. Medical Recombinant III Humanized Collagen Patch Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions